A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Clinical trial NCT00875667 · COMPLETED
Trial details
- NCT number
- NCT00875667
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-30
- Primary completion
- 2018-06-28
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.